SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection

SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection

The declaration of the conclusion of the COVID-19 pandemic notwithstanding, coronavirus remains prevalent in circulation, and the potential emergence of novel variants of concern introduces the possibility of new outbreaks. Moreover, it is not clear how quickly and to what extent the effectiveness o...

Full description

Bibliographic Details
Main Authors: Alexander Suvorov, Svetlana Loginova, Galina Leontieva, Tatiana Gupalova, Yulia Desheva, Dmitry Korzhevskii, Tatiana Kramskaya, Elena Bormotova, Irina Koroleva, Olga Kopteva, Olga Kirik, Veronika Shchukina, Sergey Savenko, Dmitry Kutaev, Sergey Borisevitch
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Vaccines
Subjects:
recombinant probiotic-based vaccines
probiotic strain <i>E. faecium</i> L3
mucosal vaccines
SARS-CoV-2 spike protein
vaccine efficacy
Online Access:https://www.mdpi.com/2076-393X/11/11/1714

Internet

https://www.mdpi.com/2076-393X/11/11/1714

Similar Items